We report a 24 year old female with growth retardation, microcephaly, and congenital abnormalities who has an unbalanced de novo translocation between chromosomes 16 and 6: 45,XX,t(6;15)(q25;qll.2). FISH analysis confirmed that the deletion on chromosome 15 is proximal to the PraderWilli locus. Several genes have been assigned to the 6q25-qter region including the insulin-like growth factor II/mannose-6-phosphate (IGF-IIIM6P) receptor. DNA analysis from our patient documented the loss of one IGF2R gene copy. These data confirm the localisation of the IGF2R receptor to distal 6q25.
The insulin-like growth factor II/mannose-6-phosphate (IGF-II/M6P) receptor gene has been mapped to 6q26-27.'2 IGF2R is located in a region of other syntenic genes on human chromosome 6 and mouse chromosome 17. This receptor is imprinted in the mouse. 
Clinical data
The patient is a white female, the third child born to non-consanguineous parents. The mother was aged 39 at conception and the father was aged 49. The pregnancy and delivery were uncomplicated. Birth weight was 3070 g (5th centile) and head circumference 32 cm (5th centile). At birth she was noted to have bilateral choanal atresia, hypotonia, and congenital hip dislocation. Since birth she has shown global developmental delay with growth retardation, height, weight, and head circumference remaining below the 2nd centile.
On examination at the age of 24 her height was 1 49 m (<2nd centile), weight was 40 kg (<2nd centile), and head circumference was 51 cm (<2nd centile). The face was triangular with a long, narrow forehead, a high nasal bridge, and malar hypoplasia. Hypotelorism was present with mild left esotropia. The palate was high arched. The teeth were crowded with gingival hypertrophy. There was mild hirsutism and a low posterior hairline. The patient had small hands with proximally placed thumbs. Skeletal abnormalities included a right convex thoracic and left lumbar scoliosis with absence of the 12th ribs bilaterally. Sexual 15 5,mol/l. The reaction was "hot started" by adding the Taq polymerase only after the rest of the reaction mixture had been heated to 94°C. Following three minutes of denaturation at 94°C, 22 cycles were performed, involving 30 seconds denaturation at 94°C, 30 seconds annealing at 60°C, 30 seconds ramp to 72°C, and 90 seconds extension at 72°C. A 10 minute final extension step was added after the last cycle.
The radiolabelled PCR products were resolved in 8% polyacrylamide and the total intensity of the bands quantitated by contact exposure to a phosphor plate using the Fuji Bio Imager. The ratio of the IGF2R band over IGF1 was calculated for the patient and each control. The patient's value was then expressed as a percentage of each control in the same experiment.
RELATIVE QUANTITATION OF THE SOLUBLE IGF-II/M6P RECEPTOR
We used the method described by Hardoin et al.6 One microlitre of serum was denatured in SDS and subjected to denaturing polyacrylamide gel electrophoresis (SDS-PAGE) in a BioRad mini apparatus, followed by electroblotting on nitrocellulose, and renaturing of the protein by extensive washing. The membrane was probed with radioiodinated IGF-II. The peptide was a gift ofEli Lilly (Indianapolis, IN) and was labelled by the chloramine T method to a specific activity of approximately 150 Ci/g. Autoradiographs of the blot were quantitated on an LKB laser densitometer.
RELATIVE QUANTITATION OF THE PHYSIOLOGICALLY ACTIVE MEMBRANE ASSOCIATED RECEPTOR
Cells were grown in 10% fetal bovine serum, harvested at confluence, and homogenised in 3M sucrose. Receptor bearing membranes (plasma membranes and Golgi endosomes) were obtained by high speed centrifugation (100 000 x g for one hour) following partial purification with a low speed run (15 000 x g for 15 minutes). The membranes were labelled with radioiodinated IGF-II by incubating overnight at 4°C in a shaking bath, in the presence or absence of excess unlabelled IGF-II.7 After washing, hormone receptor complexes were cross linked with 2% disuccinimidyl suberate, and the membranes were solubilised and subjected to SDS-PAGE on 7% polyacrylamide. The gel was dried and exposed to x ray film. The intensity of the bands was quantitated using an LKB laser densitometer. 2) . IGF2R gene dosage was determined by quantitative PCR. The patient's DNA was used as template to amplify a 204 bp IGF2R cDNA fragment, corresponding to bases 8141-8345 of the published sequence.8 An 180 bp fragment ofthe third exon ofthe insulin-like growth factor I gene (IGF1) on chromosome 12 was also amplified as a reference sequence, since the patient had no detectable cytogenetic abnormality at that locus. The ratio of the intensities of the IGF2R and IGF1 PCR products was compared between the patient and four controls in three separate experiments.
Preliminary work showed, under these conditions, a linear relationship between the amount of DNA template and the intensity of each of the two PCR product bands over a 25-fold range of amount of template added ( fig  3A) .
The ratio of the IGF2R band over the IGF1 band in the DNA of four normal subjects in three separate amplifications ranged from 0 79 to 0 93. The corresponding ratio in the patient's DNA, amplified along side the controls in each experiment, was consistently lower. Expressed as a percentage of the corresponding control ratio, it was 56%, 37%, 42%, and 58%, giving a mean of 48-25% consistent with half the IGF2R DNA dosage in the patient.
A truncated form of the IGF-II/M6P receptor has been shown to circulate in human plasma. This 230 kDa proteolytic cleavage form comprises practically all of the extracellular domain, retains full binding activity for both IGF-II and M6P, and appears to correlate with the general abundance of the receptor molecule in tissues.9 10 Relative quantitation of this receptor form was performed in the patient's plasma using the technique of ligand blotting.9
The 230 kDa bands, representing the soluble IGF-II/M6P receptor in the serum of the patient, were compared with those of seven healthy young adult women (fig 4) . The bands Relative quantitation of the physiologically active membrane associated receptor was also performed, using 100 lg of purified microsomal membrane protein from early passage cul-cultured fibroblasts from the patient and an the age matched normal female control, by affinity and cross linking. XX, Again, the intensity of the 250 kDa IGF-II/ able M6P-R band of the patient was approximately eted half that of the control (fig 5) . ceptor pair provides a rare opportunity to gain Othen solubilised and subjected to insight into the process of parental imprinting.
toradiography.
The measurement of the soluble and membrane associated forms of IGF-II/M6P-R in our patient shows it to be significantly lower such as malformations of the than in age matched controls. In addition, gans, and brain. Our patient quantitative DNA studies indicated that one reion features of distal chro-gene copy is deleted. letion including mental reThis locus has been shown to be parentally ypotonia, growth deficiency, imprinted in the mouse. If this were indeed an epicanthus, and hand ab-imprinted locus in the human, then viability of cifically as a feature of deletion a 6q deletion would be dependent on inient, in common with the 6q25 heritance of the deleted chromosome from the Liberfarb et al, ' has choanal father. In the presence of parental imprinting g that this may be specific to and the coexistence of a parental deletion one o this band.5 In common with would expect to observe an all or none phetion case of Meng et al,' our nomenon, measurable in terms of the protein -ed a long upper lip, scoliosis, product. Thus, the protein product would be sis. We did not detect internal completely absent or 100% present. We have such as urological, cardio-observed a gene dosage effect at this locus in ctural brain anomalies.
our patient in that 50% of the normal amount is a role in the internalisation of the protein product was present. This is cell surface and leads to de-compatible with expression from both gene F2, it has been suggested that copies in this patient and in accordance with , IGF2 levels in the circulation, previous expression studies. 
